.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Cipla
Colorcon
Chinese Patent Office
Daiichi Sankyo
Argus Health
Federal Trade Commission
US Army
McKesson

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,150,366

« Back to Dashboard

Which drugs does patent 6,150,366 protect, and when does it expire?


Patent 6,150,366 protects GEODON and is included in two NDAs. There has been one Paragraph IV challenge on Geodon.

This patent has fifty-seven patent family members in forty-three countries.

Summary for Patent: 6,150,366

Title: Ziprasidone formulations
Abstract:Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 .mu.m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.
Inventor(s): Arenson; Daniel R. (East Lyme, CT), Busch; Frank Robert (Gales Ferry, CT), Hausberger; Angela G. (East Lyme, CT), Rasadi; Bijan (Groton, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/320,985
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form; Device; Use; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001ABRXYesYes6,150,366► SubscribeY
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001ABRXYesNo6,150,366► SubscribeY
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-003Feb 5, 2001ABRXYesNo6,150,366► SubscribeY
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-004Feb 5, 2001ABRXYesNo6,150,366► SubscribeY
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006DISCNNoNo6,150,366► SubscribeY TREATENT OF PSYCHOSIS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,150,366

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO)1216► Subscribe
African Regional IP Organization (ARIPO)9901579► Subscribe
Argentina015553► Subscribe
Austria240732► Subscribe
Australia3398399► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Deloitte
Merck
McKinsey
Medtronic
Argus Health
Healthtrust
Cantor Fitzgerald
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot